Chronic myeloid leukemia following nasopharyngeal carcinoma

Chronic myeloid leukemia following nasopharyngeal carcinoma

We describe a case of 48 year old woman with chronic myeloid leukemia (CML) occurring 13 years after a nasopharyngeal carcinoma treated with chemotherapy and radiotherapy. Bone marrow cytogenetic study demonstrated the presence of the t(9.22) and the molecular biology study showed rearrangement b2a2...

Full description

Saved in:

Bibliographic Details
Main Author:	olfa kassar
Format:	Article
Language:	English
Published:	PAGEPress Publications 2014-08-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	therapy-related leukemia chronic myeloid leukemia nasopharyngeal cancer
Online Access:	https://mjhid.org/index.php/mjhid/article/view/1914
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01)

OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY
by: Mohamed Amine BEKADJA
Published: (2017-10-01)

Unraveling the unexpected: A rare case of filariasis in chronic myeloid leukemia with a review of the literature
by: Nikhil Kumar
Published: (2024-09-01)

TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2014-01-01)

Delayed manifestation of proliferative retinopathy associated with chronic myeloid leukemia
by: Alan Chew Bonilla, et al.
Published: (2024-12-01)

Role of MicroRNAs in Chronic Myeloid Leukemia (CML) Treatment, Biomarkers, and Resistance to Tyrosine Kinase Inhibitor: A Bioinformatics-Based Analysis
by: Syarifah Faezah binti Syed Mohamad, et al.
Published: (2024-11-01)

Data and implication based comparison of two chronic myeloid leukemia models
by: R. A. Everett, et al.
Published: (2013-07-01)

Impact of Hemoglobin, Leucocyte and Thrombocyte Levels at Diagnosis on the Survival Outcomes of Chronic Myeloid Leukemia Patients
by: Taha Ulutan Kars, et al.
Published: (2024-02-01)

Hyperoside induces ferroptosis in chronic myeloid leukemia cells by targeting NRF2
by: Junyi Wei, et al.
Published: (2024-11-01)

Anuric Acute Kidney Injury in Chronic Myeloid Leukemia: A Rare Complication Case
by: Angela Kimberly Tjahjadi, et al.
Published: (2024-10-01)

INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
by: Caterina Giovanna Valentini, et al.
Published: (2011-12-01)

INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
by: Morena Caira, et al.
Published: (2011-01-01)

SOCIAL AND FINANCIAL BARRIERS TO OPTIMUM TKI TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA- A KNOWLEDGE-ATTITUDES-PRACTICES STUDY FROM INDIA
by: Naveen Gupta, et al.
Published: (2021-01-01)

Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome – a retrospective analysis of the Polish Adult Leukemia Group
by: Aleksandra Gołos, et al.
Published: (2024-07-01)

Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption
by: Judit Demeter, et al.
Published: (2021-02-01)

Coexistence of P190 BCR/ABL transcript and CALR 52-bp deletion in chronic myeloid leukemia blast crisis: a case report
by: najmaldin saki, et al.
Published: (2016-01-01)

Novel targeted therapies in chronic myeloid leukemia
by: Muhammad Sameer Ashaq, et al.
Published: (2024-12-01)

IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?
by: Federica Sorà, et al.
Published: (2021-10-01)

THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA
by: Enas A Dammag, et al.
Published: (2020-01-01)

THE EFFECT OF IMATINIB MESYLATE IN NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE, CHRONIC-PHASE MYELOID LEUKEMIA IN SUB-SAHARAN AFRICAN PATIENTS: THE EXPERIENCE OF CÔTE D’IVOIRE
by: GUSTAVE Kouassi KOFFI, et al.
Published: (2014-08-01)

LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
by: Massimo Breccia, et al.
Published: (2011-05-01)

LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
by: Michelina Santopietro, et al.
Published: (2011-01-01)

Menin inhibitors for the treatment of acute myeloid leukemia: challenges and opportunities ahead
by: Kalyan V. G. Nadiminti, et al.
Published: (2024-11-01)

Function and mechanism of cancer-testis antigen CT63 in chronic myeloid leukemia
by: KONG Ruxin, et al.
Published: (2024-11-01)

Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data
by: Petra Belohlavkova, et al.
Published: (2024-09-01)

Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents
by: Dian Jin, et al.
Published: (2024-07-01)

Infant acute myeloid leukemia: insights into the biology and therapy
by: Xiaoli Chen, et al.
Published: (2024-12-01)

Hematological profile and its correlation with reverse transcription–polymerase chain reaction-based serial quantitative detection of BCR-ABL in chronic myeloid leukemia patients at a referral cancer center
by: Vanita Pandey, et al.
Published: (2024-12-01)

Interaction of xanthoxyletin with protein, molecular docking and antitumor activity in human chronic myeloid leukemia K562 cells
by: Chen Wang, et al.
Published: (2024-12-01)

Pediatric and adolescent chronic myeloid leukemia: A follow-up study in Western India
by: Sangita A. Vanik, et al.
Published: (2023-07-01)

Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine
by: Mihee Kim, et al.
Published: (2024-12-01)

Prognostic criteria of chronic myeloid leukemia by changes platelets sizes
by: Shorop Y.V., et al.
Published: (2016-03-01)

Prognostic criteria of chronic myeloid leukemia by changes platelets sizes.
by: Y. V. Shorop, et al.
Published: (2016-03-01)

OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
by: Grzegorz Helbig, et al.
Published: (2015-01-01)

CD56briCD38+ as a novel neutrophil-specific marker in chronic myeloid leukemia
by: Panpan Huang, et al.
Published: (2024-11-01)

Monitoring the response to tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML)
by: Ibrahim C. Haznedaroglu
Published: (2014-08-01)

Dynamics of Chronic Myeloid Leukemia Under Imatinib Treatment: A Study of Resistance Development
by: Irina Badralexi, et al.
Published: (2024-12-01)

Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia
by: Alvea Tasneem, et al.
Published: (2024-12-01)

COMPLETE REMISSION IN A PATIENT WITH CONCOMITANT DIAGNOSIS OF ACUTE MYELOID LEUKEMIA AND PULMONARY MUCORMICOSIS
by: saveria capria, et al.
Published: (2014-08-01)

EXTRAMEDULLARY INVOLVEMENT IN ACUTE MYELOID LEUKEMIA. A SINGLE CENTER TEN YEARS EXPERIENCE
by: Luana Fianchi, et al.
Published: (2021-04-01)